Eli Keshet
J Clin Invest.
2003;
112(1):27–29
doi:10.1172/JCI19093
This article Copyright © 2003, The American Society for Clinical Investigation
Abstract
|
Full text
|
PDF
O
xygen administration to premature infants suppresses retinal VEGF expression and results in the catastrophic vessel loss associated with retinopathy of prematurity. A study investigating the development of the retinal vasculature in mice (see related article on pages 50–57) demonstrates that specific activation of VEGF receptor-1 by placental growth factor-1 protects against oxygen-induced vessel loss without stimulating vascular proliferation and neovascularization.